Search

Search bills, members, committees and pages...

ALEXION PHARMACEUTICALS

16 federal lobbying filings, 2024 to 2026.

ALEXION PHARMACEUTICALS is a client on 16 federal lobbying filings, 2024 to 2026, reporting $130K across them. Biopharmaceutical company Based in Massachusetts.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

2 it has hired, by filings.

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$20K
20259$65K
20245$45K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues13
MMMMedicare/Medicaid5

Lobbyists

Named on the filings.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
ALEXION PHARMACEUTICALSJEFFREY J. KIMBELL & ASSOCIATES, INC.2026 second_quarter$10KJul 20, 2026
ALEXION PHARMACEUTICALSJEFFREY J. KIMBELL & ASSOCIATES, INC.2026 first_quarter$10KApr 20, 2026
ALEXION PHARMACEUTICALSJEFFREY J. KIMBELL & ASSOCIATES, INC.2025 fourth_quarter$10KJan 20, 2026
ALEXION PHARMACEUTICALSMANATT, PHELPS, AND PHILLIPS2025 fourth_quarterJan 20, 2026
ALEXION PHARMACEUTICALSJEFFREY J. KIMBELL & ASSOCIATES, INC.2025 third_quarter$10KOct 20, 2025
ALEXION PHARMACEUTICALSMANATT, PHELPS, AND PHILLIPS2025 third_quarter$15KOct 16, 2025
ALEXION PHARMACEUTICALSJEFFREY J. KIMBELL & ASSOCIATES, INC.2025 second_quarterJul 21, 2025
ALEXION PHARMACEUTICALSMANATT, PHELPS, AND PHILLIPS2025 second_quarter$15KJul 17, 2025
ALEXION PHARMACEUTICALSMANATT, PHELPS, AND PHILLIPS2025 first_quarter$15KMay 6, 2025
ALEXION PHARMACEUTICALSJEFFREY J. KIMBELL & ASSOCIATES, INC.2025 first_quarterApr 18, 2025
ALEXION PHARMACEUTICALSJEFFREY J. KIMBELL & ASSOCIATES, INC.2025 first_quarterApr 18, 2025
ALEXION PHARMACEUTICALSMANATT, PHELPS, AND PHILLIPS2024 fourth_quarter$15KMar 18, 2025
ALEXION PHARMACEUTICALSMANATT, PHELPS, AND PHILLIPS2024 fourth_quarterMar 12, 2025
ALEXION PHARMACEUTICALSMANATT, PHELPS, AND PHILLIPS2024 fourth_quarter$15KJan 21, 2025
ALEXION PHARMACEUTICALSMANATT, PHELPS, AND PHILLIPS2024 fourth_quarter$15KJan 17, 2025
ALEXION PHARMACEUTICALSMANATT, PHELPS, AND PHILLIPS2024 fourth_quarterJan 16, 2025